Harlicia Farley
Family Medicine · Greenville, SCNPI 1154381036
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $405 of the $630 with a category attached, or 64.3%. Novartis accounts for 78.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $497 and has fallen 75.9% since, to $120 in 2023. That places this record below the midpoint for family medicine clinicians in SC, where the typical reported total is $473.
Across 5 payments — averaging $125.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$497
- Dexcom, Inc.$120
- AbbVie$13
Across 342 payments — averaging $3255.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$518K
- Exeltis, USA Inc.$235K
- Alnylam Pharmaceuticals Inc.$169K
- Sanofi Pasteur Inc.$122K
- Novartis$51K
- Lexicon Pharmaceuticals, Inc.$11K
- plus $7K from 1 others
What the payments were for
- Travel & lodging$22536%
- Food & beverage$40564%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 3 | $497 |
| Dexcom, Inc. | 1 | $120 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$630 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 42 | $61,176 |
| LinzessLinaclotide | 33 | $40,956 |
| TrulicityDulaglutide | 15 | $30,390 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $6,435 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $3,254 |
| Novolog FlexpenInsulin Aspart | 11 | $1,639 |
| Omeprazole | 51 | $1,102 |
| Gabapentin | 37 | $955 |
| Diclofenac Sodium | 15 | $904 |
| Fluticasone Propionate | 46 | $858 |
| Atorvastatin Calcium | 96 | $779 |
| Celecoxib | 29 | $773 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $721 |
| Rosuvastatin Calcium | 43 | $563 |
| Famotidine | 22 | $538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $13 | $40,95633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Greenville
- Steve HamberisGreenville$19K
- Richard LelandGreenville$19K
- Saria SaccocioGreenville$17K
- Eric FaileGreenville$15K
- Naveen BethiGreenville$14K
- James BridgemanGreenville$13K
- Angela SellGreenville$13K
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.